Delivery Order SPE2DB22D2211-SPE2DB25FSECQ
Award Date 9/3/25
Potential Completion Date 9/24/25
Potential Value $3.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ENVARSUS XR 1 MG tablets (100-count units) on September 19, 2025, with a ceiling value of $1,288.86 and an ultimate completion date of October 10, 2025. This firm fixed-price contract represents a non-competitive set-aside award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,711.95 to AmerisourceBergen Drug Corp for ENVARSUS XR 4 mg tablets (100 count) with an ultimate completion date of October 3, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $3,423.90 for ENVARSUS XR 4 MG tablets (100-count units) with a firm fixed price structure. The award, issued on August 26, 2025, represents a child order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,106.80 by the Defense Logistics Agency's Medical Supply Chain on September 3, 2025, with an ultimate completion date of September 24, 2025. The order is for ENVARSUS XR 1 mg tablets in a 30-count supply. This is a firm fixed-price, non-set-aside contract with performance at the company's corporate office in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on July 15, 2025, for ENVARSUS XR 4 mg tablets (100 count). The contract is valued at $1,841.40 under a firm fixed price arrangement with an ultimate completion date of August 5, 2025. This award represents a non-set-aside competitive procurement and serves as a child order under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,423.90 for ENVARSUS XR 4MG (100 tablets) by the Defense Logistics Agency's Medical Supply Chain on July 24, 2025, with completion targeted for August 14, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.76 to AmerisourceBergen Drug Corp for ENVARSUS XR 0.75 mg tablets (30-count package) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order represents a non-competitive procurement and is performed at the contractor's Conshohocken, Pennsylvania location. ENVARSUS XR is a tacrolimus-based immunosuppressant medication used in transplant and other immunological...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,711.95 firm-fixed-price contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The Defense Logistics Agency awarded a delivery order valued at $1,718.48 to AmerisourceBergen Drug Corp for the supply of Envarsus XR 1 mg tablets (100-count units) on August 7, 2025, with completion expected by August 28, 2025. This firm fixed price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division, with performance to be executed from the company's Conshohocken, Pennsylvania headquarters. The contract falls under...
- This is a $1,711.95 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with a completion date of July 2, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...